Form 4: Perrigo Executive Grainne Quinn Reports Acquisition of Restricted Stock Units

EVP and Chief Medical Officer of Perrigo, Grainne Quinn, reports acquiring 6,210 restricted stock units.

Summary

• Grainne Quinn, EVP and Chief Medical Officer of Perrigo Company plc, filed a Form 4.
• The report details the acquisition of 6,210 restricted stock units on April 5, 2024.
• These restricted stock units represent a contingent right to receive one Perrigo Company plc ordinary share each.
• The restricted stock units vest in three equal annual installments starting April 5, 2025.
• Following the transaction, Ms. Quinn directly owns 21,078 ordinary shares.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing indicating standard compensation practices. It doesn't contain overtly positive or negative information, hence a neutral to slightly positive sentiment.

Positives

• The acquisition of restricted stock units aligns the executive's interests with the company's long-term performance.
• The vesting schedule encourages continued service and contribution to Perrigo.

Future Outlook

The vesting of the restricted stock units over three years suggests a long-term commitment from the executive.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders.

Stakeholder Impact

• The acquisition of restricted stock units by a key executive can reassure shareholders about the executive's commitment to the company's success.

Key Dates